A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain

Published:2022-05-19 Issue:1 Volume:25 Page:640-649
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

González-Juanatey José Ramón¹^ORCID,González-Franco Álvaro²^ORCID,de Sequera Patricia³^ORCID,Valls Marta⁴,Ramirez de Arellano Antonio⁵,Pomares Elisenda⁶,Nieves Diana⁶

Affiliation:

1. Servicio Cardiología, Hospital Clínico Universitario de Santiago de Compostela, Santiago De Compostela, Spain

2. Servicio Medicina Interna, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain

3. Servicio Nefrología, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain

4. Market Access, Vifor Pharma Group., Barcelona, Spain

5. Global HEOR, Vifor Pharma Group, Glattbrugg, Switzerland

6. Market Access, PharmaLex, Barcelona, Spain

Funder

Vifor Pharma

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2074193

Reference47 articles.

1. Guía de Práctica Clínica sobre la Detección y el Manejo de la Enfermedad Renal Crónica

2. The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease

3. Epidemiología de la hiperpotasemia en la enfermedad renal crónica

4. Ion-Exchange Resins for the Treatment of Hyperkalemia: Are They Safe and Effective?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart Failure and Edema Costs in Patiromer and Sodium Zirconium Cyclosilicate Users;Kidney360;2024-06-05

2. Cost‐effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore;Nephrology;2024-03-05

3. Cobalt oxide modified sulfur and phosphorus Co-doped g-C3N4 for screening of urinary human albumin;Microchimica Acta;2023-08-18

4. Hyperkalemia in chronic kidney disease: a focus on potassium lowering pharmacotherapy;Expert Opinion on Pharmacotherapy;2023-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3